Ann Arbor Stage II Non-Hodgkin Lymphoma Recruiting Phase 2 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0113043 (Ann Arbor Stage II Non-Hodgkin Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs